Shaker Investments LLC OH Purchases 112 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Shaker Investments LLC OH boosted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 0.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,948 shares of the medical instruments supplier’s stock after purchasing an additional 112 shares during the quarter. Shaker Investments LLC OH owned about 0.06% of LeMaitre Vascular worth $1,285,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in LMAT. Townsquare Capital LLC lifted its holdings in LeMaitre Vascular by 38.0% in the third quarter. Townsquare Capital LLC now owns 47,953 shares of the medical instruments supplier’s stock valued at $4,454,000 after buying an additional 13,210 shares during the period. Barclays PLC raised its position in shares of LeMaitre Vascular by 394.5% during the 3rd quarter. Barclays PLC now owns 36,577 shares of the medical instruments supplier’s stock valued at $3,396,000 after acquiring an additional 29,180 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of LeMaitre Vascular by 6.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 191,511 shares of the medical instruments supplier’s stock valued at $17,789,000 after purchasing an additional 11,395 shares during the period. Creative Planning boosted its position in shares of LeMaitre Vascular by 20.7% in the 3rd quarter. Creative Planning now owns 3,594 shares of the medical instruments supplier’s stock worth $334,000 after purchasing an additional 617 shares during the last quarter. Finally, Copeland Capital Management LLC grew its stake in shares of LeMaitre Vascular by 1.0% during the third quarter. Copeland Capital Management LLC now owns 1,163,392 shares of the medical instruments supplier’s stock worth $108,068,000 after purchasing an additional 11,318 shares during the period. 84.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on LMAT shares. Cantor Fitzgerald initiated coverage on LeMaitre Vascular in a report on Tuesday, October 15th. They set a “neutral” rating and a $96.00 target price on the stock. StockNews.com lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Oppenheimer reaffirmed an “outperform” rating and issued a $93.00 target price (up previously from $90.00) on shares of LeMaitre Vascular in a research note on Friday, November 1st. Finally, Barrington Research lifted their price target on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a research report on Friday, November 1st. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.57.

Insiders Place Their Bets

In other news, Director Bridget A. Ross sold 3,750 shares of LeMaitre Vascular stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.47, for a total value of $380,512.50. Following the sale, the director now directly owns 2,278 shares in the company, valued at $231,148.66. This trade represents a 62.21 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 10.79% of the company’s stock.

LeMaitre Vascular Stock Up 0.5 %

Shares of LMAT stock opened at $98.44 on Tuesday. LeMaitre Vascular, Inc. has a 12-month low of $58.66 and a 12-month high of $109.58. The firm has a fifty day moving average of $96.58 and a 200-day moving average of $93.28. The company has a market capitalization of $2.21 billion, a price-to-earnings ratio of 53.79, a P/E/G ratio of 2.19 and a beta of 0.96.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.